Patent · US Active

Silylated pyrimidine prodrugs and methods of their use

US10479807B2 · kind B2 · utility

0Cited by
5References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 8, 2015
Grant dateNov 19, 2019
Priority date—
Expiry dateOct 8, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Silylated-pyrimidine prodrugs, compositions that include the silylated-pyrimidine prodrugs, methods for making the silylated-pyrimidine prodrugs and compositions, and methods for treating cancer using the silylated-pyrimidine prodrugs and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.